Grant: Alliance Grants
Université de Sherbrooke
$45,000.00
Extracellular matrix grafts for the treatment of volumetric muscle loss
EF 2024-25
Résumé
Musculoskeletal injuries are one of the most frequent reasons for emergency room visits and make up over 75% of battlefield wounds in modern combat. Skeletal muscle, one of the most abundant tissues of the human body, has a remarkable regenerative capacity mediated by tissue resident myogenic progenitors (MPs). However, MPs require an extracellular matrix (ECM) template to efficiently repair damaged muscle tissue. Volumetric muscle loss (VML) is caused by excision of large portions of skeletal muscle as a consequence of injuries or surgery. Due to the absence of an organized ECM and their limited migratory capacity, MPs in unaffected areas of skeletal muscle adjacent to the injury fail to efficiently repopulate and repair the VML site. As a result, VML frequently results in chronic functional deficits and disability that have a considerable socioeconomic impact. Over the recent years we have developed sophisticated methods for decellularization of skeletal muscle tissue. By providing guidance cues for endogenous MPs, these ECM scaffolds hold great therapeutic promise as grafts for VML injuries. Here, we assembled an interdisciplinary team of bioengineers and stem cell biologists to develop a microfabricated polysulfone cell culture chamber system to assess the ability of MPs to migrate into and repopulate fibrin gel embedded ECM scaffolds. These experiments will, for the first time, provide an in-vitro platform to assess the potential of ECM scaffold preparations as grafts for VML injuries. In parallel experiments, we will test the efficiency of our decellularized fibrin embedded skeletal muscle ECM scaffolds to promote the repair of VML injuries in mice. Lastly, in a third, partially interdependent aim, we will test a library of previously identified and novel pro-migratory growth factors for their ability to stimulate the recellularization of ECM scaffolds in our in-vitro system and subsequently in our mouse model of VML. Ultimately, our work will inspire the development of much needed novel therapeutic avenues for the treatment of VML. A surgical intervention that is capable to enhance the repair of VML injuries represents an opportunity to ease the burdens of daily living for thousands of patients each year.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
577534-2022
Name nom
Bentzinger, Florian CF
Department département
Pharmacologie-physiologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
45000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Extracellular matrix grafts for the treatment of volumetric muscle loss
Keywords
atomic force microscopy; biomaterials; extracellular matrix; hydrogels; muscle stem cells; satellite cells; skeletal muscle; stem cell migration; tissue regeneration; volumetric muscle loss
Application summary
Musculoskeletal injuries are one of the most frequent reasons for emergency room visits and make up over 75% of battlefield wounds in modern combat. Skeletal muscle, one of the most abundant tissues of the human body, has a remarkable regenerative capacity mediated by tissue resident myogenic progenitors (MPs). However, MPs require an extracellular matrix (ECM) template to efficiently repair damaged muscle tissue. Volumetric muscle loss (VML) is caused by excision of large portions of skeletal muscle as a consequence of injuries or surgery. Due to the absence of an organized ECM and their limited migratory capacity, MPs in unaffected areas of skeletal muscle adjacent to the injury fail to efficiently repopulate and repair the VML site. As a result, VML frequently results in chronic functional deficits and disability that have a considerable socioeconomic impact. Over the recent years we have developed sophisticated methods for decellularization of skeletal muscle tissue. By providing guidance cues for endogenous MPs, these ECM scaffolds hold great therapeutic promise as grafts for VML injuries. Here, we assembled an interdisciplinary team of bioengineers and stem cell biologists to develop a microfabricated polysulfone cell culture chamber system to assess the ability of MPs to migrate into and repopulate fibrin gel embedded ECM scaffolds. These experiments will, for the first time, provide an in-vitro platform to assess the potential of ECM scaffold preparations as grafts for VML injuries. In parallel experiments, we will test the efficiency of our decellularized fibrin embedded skeletal muscle ECM scaffolds to promote the repair of VML injuries in mice. Lastly, in a third, partially interdependent aim, we will test a library of previously identified and novel pro-migratory growth factors for their ability to stimulate the recellularization of ECM scaffolds in our in-vitro system and subsequently in our mouse model of VML. Ultimately, our work will inspire the development of much needed novel therapeutic avenues for the treatment of VML. A surgical intervention that is capable to enhance the repair of VML injuries represents an opportunity to ease the burdens of daily living for thousands of patients each year.